The Latest Cardiac and Vascular News
Comaneci™ temporarily expands blood vessels–recognized as novel device for life-threatening disease YOKNEAM, Israel & MIAMI–(BUSINESS WIRE)–Rapid Medical, a leading developer of advanced neurovascular devices, today announced FDA breakthrough designation for its Comaneci™ embolization assist device to facilitate the treatment of cerebral vasospasm following hemorrhagic stroke. Vasospasm is a major complication and cause of morbidity. […]
Newest addition to company’s Zoom Stroke Solution allows for quick confirmation of successful clot retrieval during mechanical thrombectomy for ischemic stroke CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced the launch of its Zoom POD™ Aspiration Tubing, the company’s latest innovation in elevating stroke care. The Zoom POD is the newest addition […]
WHIPPANY, N.J.–(BUSINESS WIRE)–Bayer today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for its investigational drug asundexian (BAY2433334) as a potential treatment for secondary prevention in patients with a non-cardioembolic ischemic stroke. Asundexian is an oral inhibitor of Factor Eleven (FXIa) 1 that Bayer is developing […]
Perfuze develops catheter-based technology for treating acute ischemic stroke Financing was led by new investors LSP and Seroba Life Sciences and joined by new investor SV Health Investors and existing investors GALWAY, Ireland–(BUSINESS WIRE)–Perfuze, a medical device company developing next-generation catheter-based aspiration technology to treat large vessel occlusion acute ischemic […]
BOSTON, Feb. 8, 2022 /PRNewswire/ — CereVasc, Inc., a privately held, clinical-stage, medical device company developing novel, minimally invasive treatments for neurological diseases, announced today that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) application to initiate a pilot trial of the eShunt System in patients […]
SAN MATEO, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) — Route 92 Medical, Inc., a private medical technology company dedicated to becoming the performance leader in acute ischemic stroke intervention, today announced the first patient enrollment in its SUMMIT MAX clinical trial. SUMMIT MAX is a randomized, controlled, multi-center trial to […]
Ontario, Canada, Feb. 03, 2022 (GLOBE NEWSWIRE) — Kitchener, ON – February 3, 2022– Vena Medical is excited to announce the first Health Canada Medical Device License for their new product, the Vena Balloon Distal Access Catheter™[1] (BDAC). The Vena BDAC™ combines the balloon guide catheters and distal access catheters that are currently […]
TEL AVIV, Israel, Jan. 20, 2022 /PRNewswire/ — BENDIT Technologies, a company focused on the development of steerable microcatheters, announced today the successful first use in the USA of the BENDIT21 neuro catheter in a life-saving treatment. The case involved a 57-year-old female patient who had been suffering for years from an inoperable symptomatic […]
The objective of this study is to obtain data on the technical feasibility, safety, and efficacy of the second-generation eCLIPs products for the treatment of bifurcation aneurysms. VANCOUVER, British Columbia–(BUSINESS WIRE)–Evasc Neurovascular, a pioneer in the development of disruptive endovascular treatments for cerebral aneurysms, announced today the enrollment of the […]
HINGHAM, Mass., Dec. 27, 2021 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT) announced that it has entered into a strategic collaboration agreement with Stryker, a leading global medical technology company. The company will collaborate with Stryker’s Neurovascular division to integrate its neurovascular instruments with Microbot’s LIBERTY Robotic System to […]
